Study of AXL1717 Compared to Docetaxel to Treat Squamous Cell Carcinoma or Adenocarcinoma of the Lung
Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare effectiveness and safety of experimental anticancer
medicine, AXL1717, and docetaxel in patients with squamous cell carcinoma or adenocarcinoma
of the lung.